The lipids of Pneumocystis carinii

E S Kaneshiro1

  • 1Department of Biological Sciences, University of Cincinnati, Ohio 45221, USA. Edna.Kaneshiro@uc.edu

Insights

Pneumocystis carinii lipids offer drug targets. Research identifies specific P. carinii lipids and metabolic pathways, aiding in developing new treatments for P. carinii pneumonia.

Area of Science:

  • Medical Mycology
  • Biochemistry
  • Drug Discovery

Background:

  • Pneumocystis carinii is an opportunistic pathogen often associated with AIDS.
  • Lipids unique to P. carinii are potential targets for novel drug development.
  • Understanding P. carinii lipid metabolism is crucial for treating P. carinii pneumonia.

Purpose of the Study:

  • To investigate P. carinii-specific lipids and their biosynthetic pathways.
  • To explore the potential of targeting P. carinii lipid synthesis for therapeutic intervention.
  • To understand the biochemical abnormalities in the lungs caused by P. carinii infection.

Main Methods:

  • Analysis of lipids from purified P. carinii organisms isolated from infected rat lungs.
  • Examination of delta 7C-24-alykylated sterol and cis-9,10-epoxystearic acid biosynthesis.
  • Study of bronchoalveolar lavage fluid and infected lung tissue chemistry.

Main Results:

  • P. carinii synthesizes unique lipids, including delta 7C-24-alykylated sterols and cis-9,10-epoxystearic acid.
  • Atovaquone's efficacy suggests differences in the pathogen's electron transport chain.
  • P. carinii infection alters lung surfactant proteins and phospholipids, potentially due to phospholipase activity and pathogen lipid uptake.

Conclusions:

  • P. carinii lipids represent promising targets for developing new anti-Pneumocystis drugs.
  • Inhibiting specific lipid biosynthetic pathways, like sterol alkylation, may yield effective treatments.
  • Further research into P. carinii's reliance on exogenous lipids could reveal new therapeutic strategies.

Related Concept Videos

Membrane Lipids01:32

Membrane Lipids

Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...